Chiarotto Alessandro, Terwee Caroline B, Deyo Richard A, Boers Maarten, Lin Chung-Wei Christine, Buchbinder Rachelle, Corbin Terry P, Costa Leonardo O P, Foster Nadine E, Grotle Margreth, Koes Bart W, Kovacs Francisco M, Maher Chris G, Pearson Adam M, Peul Wilco C, Schoene Mark L, Turk Dennis C, van Tulder Maurits W, Ostelo Raymond W
Department of Health Sciences, Faculty of Earth & Life Sciences, EMGO+ Institute for Health and Care Research, VU University, de Boelelaan 1085, 1081HV Amsterdam, The Netherlands.
Trials. 2014 Dec 26;15:511. doi: 10.1186/1745-6215-15-511.
Low back pain (LBP) is one of the most disabling and costly disorders affecting modern society, and approximately 90% of patients are labelled as having non-specific LBP (NSLBP). Several interventions for patients with NSLBP have been assessed in clinical trials, but heterogeneous reporting of outcomes in these trials has hindered comparison of results and performance of meta-analyses. Moreover, there is a risk of selective outcome reporting bias. To address these issues, the development of a core outcome set (COS) that should be measured in all clinical trials for a specific health condition has been recommended. A standardized set of outcomes for LBP was proposed in 1998, however, with evolution in COS development methodology, new instruments, interventions, and understanding of measurement properties, it is appropriate to update that proposal. This protocol describes the methods used in the initial step in developing a COS for NSLBP, namely, establishing a core domain set that should be measured in all clinical trials.
METHODS/DESIGN: An International Steering Committee including researchers, clinicians, and patient representatives from four continents was formed to guide the development of this COS. The approach of initiatives like Core Outcome Measures in Effectiveness Trials (COMET) and Outcome Measures in Rheumatology (OMERACT) was followed. Participants were invited to participate in a Delphi study aimed at generating a consensus-based core domain set for NSLBP. A list of potential core domains was drafted and presented to the Delphi participants who were asked to judge which domains were core. Participant suggestions about overlap, aggregation, or addition of potential core domains were addressed during the study. The patients' responses were isolated to assess whether there was substantial disagreement with the rest of the Delphi panel. A priori thresholds for consensus were established before each Delphi round. All participants' responses were analysed from a quantitative and qualitative perspective to ascertain that no substantial discrepancies between the two approaches emerged.
We present the initial step in developing a COS for NSLBP. The next step will be to determine which measurement instruments adequately cover the domains.
腰痛(LBP)是影响现代社会的最具致残性和成本高昂的疾病之一,约90%的患者被归类为非特异性腰痛(NSLBP)。针对NSLBP患者的几种干预措施已在临床试验中进行了评估,但这些试验中结果报告的异质性阻碍了结果的比较和荟萃分析的进行。此外,还存在选择性结果报告偏倚的风险。为解决这些问题,有人建议制定一个核心结局集(COS),所有针对特定健康状况的临床试验都应测量该结局集。1998年提出了一套标准化的腰痛结局指标,然而,随着COS开发方法、新工具、干预措施以及对测量特性理解的发展,更新该提议是合适的。本方案描述了为NSLBP开发COS的初始步骤中所使用的方法,即确定所有临床试验都应测量的核心领域集。
方法/设计:成立了一个国际指导委员会,成员包括来自四大洲的研究人员、临床医生和患者代表,以指导该COS的开发。遵循了有效性试验核心结局指标(COMET)和风湿病结局指标(OMERACT)等倡议的方法。邀请参与者参加一项德尔菲研究,旨在为NSLBP生成一个基于共识的核心领域集。起草了一份潜在核心领域列表,并提交给德尔菲参与者,要求他们判断哪些领域是核心领域。在研究过程中,处理了参与者关于潜在核心领域的重叠、汇总或添加的建议。将患者的回答单独分离出来,以评估是否与德尔菲小组的其他成员存在重大分歧。在每轮德尔菲之前确定共识的先验阈值。从定量和定性的角度分析所有参与者的回答,以确定两种方法之间没有出现重大差异。
我们展示了为NSLBP开发COS的初始步骤。下一步将是确定哪些测量工具能够充分涵盖这些领域。